NPI-031G (puerarin) reduces anxiogenic effects of alcohol withdrawal or benzodiazepine inverse or 5-HT2C agonists

Pharmacol Biochem Behav. 2003 Jun;75(3):619-25. doi: 10.1016/s0091-3057(03)00114-x.

Abstract

Because extracts of kudzu have been used as a hangover remedy in China for many centuries, we tested the ability of NPI-031G (puerarin), an isoflavone isolated from kudzu, to counteract anxiogenic effects associated with withdrawal from chronic alcohol exposure. NPI-O31G (50 and 150 mg/kg ip) significantly increased the social interaction and locomotor activity reduced by withdrawal from 17 days of alcohol (7%) diet. The effects of NPI-031G resembled those of the benzodiazepine antagonist, flumazenil (5 mg/kg), and the 5-HT(2C) antagonist, SB 242084 (1 mg/kg). In a separate study, control rats were pretreated with NPI-031G (30 min) and then given the anxiogenic compounds DMCM, a benzodiazepine inverse agonist, or Ro 600175, a 5-HT(2C) agonist. NPI-031G significantly counteracted the reduction in social interaction induced by either compound. To identify a potential mechanism of action of NPI-031G, synaptoneurosomes were isolated from the cerebral cortex of untreated rats and chloride uptake assays were carried out. NPI-031G did not have any effect on the stimulation of chloride uptake by muscimol, a GABA(A) agonist. However, it reduced the potentiation of muscimol-stimulated chloride uptake by flunitrazepam, a benzodiazepine agonist, at a concentration of 100 microM. A reduction in [3H]flunitrazepam binding was also seen at this concentration. These findings are consistent with NPI-031G being a weak benzodiazepine site antagonist.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alcoholism / drug therapy*
  • Alcoholism / metabolism
  • Alcoholism / psychology
  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Anti-Anxiety Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • GABA-A Receptor Agonists*
  • GABA-A Receptor Antagonists
  • Interpersonal Relations
  • Isoflavones / pharmacology
  • Isoflavones / therapeutic use*
  • Male
  • Protein Binding / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT2C / metabolism
  • Receptors, GABA-A / metabolism
  • Serotonin 5-HT2 Receptor Agonists*
  • Serotonin Receptor Agonists / metabolism
  • Serotonin Receptor Agonists / pharmacology
  • Substance Withdrawal Syndrome / drug therapy*
  • Substance Withdrawal Syndrome / metabolism
  • Substance Withdrawal Syndrome / psychology

Substances

  • Anti-Anxiety Agents
  • GABA-A Receptor Agonists
  • GABA-A Receptor Antagonists
  • Isoflavones
  • Receptor, Serotonin, 5-HT2C
  • Receptors, GABA-A
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin Receptor Agonists
  • puerarin